drugset / Trial / NCT02310074

Efficacy and Safety of Pulsatile Gonadotropin Releasing Hormone Pump Treatment in Patients With Idiopathic Hypogonadotropic Hypogonadism

NCT02310074

Non-randomizedParallel-groupOpen-labelTreatment

Summary

Idiopathic hypogonadotropic hypogonadism (IHH) is the most common disorders of sex development (DSD).Therapy for IHH includes hormone replacement therapy, gonadotropin therapy and pulsed infusion of gonadotropin releasing hormone (GnRH).In the present study, we compared the different efficacy and safety of pulsatile GnRH pump therapy with combination gonadotropin therapy on fertility and sexual development in male patients with IHH.

Timeline

Start
2010-01
Primary completion
2014-06
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bravelle Unknown
Subject Pulsatile Gonadotropin Releasing Hormone Unknown Subcutaneous
Comparator human chorionic gonadotropin Protein / enzyme biologic